Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Merck & Co., Inc. (NY: MRK)
47.58 USD  -0.17 (-0.36%)
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Merck & Co., Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
An AstraZeneca And Bristol-Myers Diabetes Trial Is A Dud
Today 13:25 EDT
In a setback to an important joint venture between Bristol-Myers Squibb and AstraZeneca, the top-line results of a large, late-stage study of their Onglyza diabetes drug failed to show superiority in... Read More
category NYSE:MRK , NYSE:BMY , NYSE:AZN
from Forbes Real Time
No More Secrets: Medtronic Shows How Open Science Might Work In The Real World
Today 11:31 EDT
Monday night, two groups of researchers released independent reviews of a back surgery device made by Medtronic, the $16 billion (sales) medical device giant. They found the product, Infuse, was no... Read More
category NYSE:MRK , NYSE:GSK , NYSE:MDT
from Forbes Real Time
EU fines Lundbeck, 8 others 146 mln euros for blocking cheaper drugs
Today 5:30 EDT
BRUSSELS, June 19 (Reuters) - EU antitrust regulators fined nine drugmakers a total of 146 million euros ($195.5 million) on Wednesday for blocking the supply of cheaper medicines on the market, with a... Read More
category companyNews
from Reuters: Company News
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
Today 2:55 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category companyNews
from Reuters: Company News
Interesting Similarities Among 2013's Top-Performing ETFs
June 18, 2013
With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what might keep working and which funds could be vulnerable to second-half... Read More
category Specialty ETFs , Benzinga , PBE , and 24 more.
from Latest Articles from Benzinga.com
Merck (MRK) Oct. Call Options See Massive Volume Spike
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8427880 for the full story. Read More
from StreetInsider.com News Articles
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers... Read More
category NYSE:MRK , NYSE:PFE , NYSE:BMY , and 1 more.
from Forbes Real Time
Trade Flow Analysis for Merck & (MRK)
June 18, 2013
NEW YORK (AVAFIN) -- A total of 12 block trades were executed during the ... Read More
from AVAFIN
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422776 for the full story. Read More
from StreetInsider.com News Articles
Merck Plans To Cut Jobs (MRK)
June 14, 2013
Pharmaceutical company Merck & Co., inc. (MRK) is planning to cut jobs and make structural changes to the organization of its research and development division. The New Jersey-based company is... Read More
category mrk , merck & co inc/ , Dividend Stocks
from Dividend Daily
Friday's ETF with Unusual Volume: XPH
June 14, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Friday, with over 119,000 shares traded versus three month average volume of about 40,000. Shares of XPH were... Read More
category ETFs
from ETF Channel
Final Trade: Your First Move for Monday, June 17
June 14, 2013
The "Fast Money" traders share their final trades of the day. Read More
category tvfmwebex , Fast Money Halftime Report , CIT Group Inc , and 9 more.
from CNBC.com News
Merck (MRK) to Further Streamline R&D Unit; Job Cuts Planned
June 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8418237 for the full story. Read More
from StreetInsider.com News Articles
Lilly Scraps An Alzheimer's Drug; What Does It Mean For Merck?
June 14, 2013
Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimer’s. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary... Read More
category NYSE:MRK , NYSE:LLY
from Forbes Real Time
Highlights on Block Activity and Options Trading for Merck & (MRK)
June 14, 2013
NEW YORK (AVAFIN) -- A total of 16 block trades were executed today, typically ... Read More
from AVAFIN
Bio-Wire Equity Surveillance – Closing Bell 6/13/2013
June 13, 2013
Thursday, June 13th, 2013 DJIA: +1.21% to 15,176.08 S&P 500: +1.48% to 1,636.36 NASDAQ: +1.32% to 3,445.37 NYSE Arca – Pharma Index: +1.05% to 429.90 Big pharma (Mkt Cap $10 B+) +1.03% Mid-sized pharma... Read More
category MYGN , MRK , Bio/Wire , and 1 more.
from Bio-Wire.Com
Merck (MRK) Crosses Pivot Point Support at $46.95
June 13, 2013
from Comtex SmarTrend® News Briefs
Income hunters: Bank on this dividend stock play
June 13, 2013
Paying a dividend vs. buying back shares is a debate investors should feel fortunate about. Companies with such a choice are fundamentally sound, and those that can do both simultaneously are even... Read More
category Earnings , VZ , T , and 59 more.
from MarketWatch
Drugmakers to cooperate in safety review of diabetes drugs
June 12, 2013
NEW YORK, June 12 (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and... Read More
category companyNews
from Reuters: Company News
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Examining Options and Block Trading Activity for Merck &
June 12, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 23 block trades on shares of Merck ... Read More
from AVAFIN
Combining Therapies to Amplify the Effects of Statins
June 11, 2013
from ACCESSWIRE
Seven Biotech Options That Buck Tradition: Christian Glennie
June 11, 2013
category Pharmaceuticals
from Trefis
Analyst Moves: MRK, BERY
June 10, 2013
This morning, UBS increased its price target on shares of Merck (MRK) to $53 as the company's pipeline remains strong, especially with Lambro. Shares of Merck were higher on the report, picking up 0.9%... Read More
category Stocks
from Market News Video
Market Wrap-Up for June 10 (AAPL, MCD, MRK, more)
June 10, 2013
The indices opened in positive territory today, seeming to continue the bullishness following Friday’s rally. However, the markets quickly erased those gains, shrugging off the S&P’s upgrade of the... Read More
category len , mcd , mrk , and 10 more.
from Dividend Daily
With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks
June 10, 2013
category Telecom , Pharmaceuticals , Semiconductor , and 1 more.
from Trefis
Merck (MRK) losts U.S. appeal of Apotex patent over Nasonex - Bloomberg
June 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8402802 for the full story. Read More
from StreetInsider.com News Articles
Jefferies Raises Price Target on Merck (MRK)
June 10, 2013
On Monday, Jefferies reported that it has increased its price target on pharmaceutical company, Merck & Co., Inc. (MRK). The firm has reiterated a “Buy” rating on MRK, and has raised the company’s... Read More
category merck & co , mrk , Dividend Stocks
from Dividend Daily
Pfizer Is Not Worried About Viagra Losing Its U.K. Patent This Month
June 10, 2013
category Pharmaceuticals
from Trefis
Pfizer Is Not Worried About Viagra Losing Its U.K. Patent This Month
June 07, 2013
category Pharmaceuticals
from Trefis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The Future of Android Looks More Like Apple Inc.
Mike Schuster
2
Boeing to Airbus: Game On
Nick Shchetko
3
The Waning Integrity of US Financial Markets
Todd Harrison
4
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
5
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer